-
Loss of β-cell KATP reduces Ca2+ sensitivity of insulin secretion and Trpm5 expression Diabetes (IF 6.2) Pub Date : 2024-12-12 Nathaniel W. York, Zihan Yan, Anna B. Osipovich, Abbie Tate, Sumit Patel, David W. Piston, Mark A. Magnuson, Maria S. Remedi, Colin G. Nichols
Loss-of-function (LOF) mutations in KATP channels cause hyperexcitability and insulin hypersecretion, resulting in congenital hyperinsulinism (CHI). Paradoxically, despite the initial insulin hypersecretion, many CHI cases, as well as KATP knockout (KO) animals, eventually ‘crossover’ to undersecretion and even diabetes. Here we confirm that Sur1 KO islets exhibit higher intracellular [Ca2+] ([Ca2+]i)
-
Adipose tissue biology and effect of weight loss in women with lipedema Diabetes (IF 6.2) Pub Date : 2024-12-09 Vincenza Cifarelli, Gordon I. Smith, Silvia Gonzalez-Nieves, Dmitri Samovski, Hector H. Palacios, Jun Yoshino, Richard I. Stein, Anja Fuchs, Thomas F. Wright, Samuel Klein
Lipedema is a lipodystrophic disease that is typically characterized by a marked increase in lower-body subcutaneous adipose tissue that is purported to have increased inflammation and fibrosis, impaired microvascular/lymphatic circulation and to be resistant to reduction by weight loss therapy. However, these outcomes have not been adequately studied. We evaluated body composition, insulin sensitivity
-
Gain of function NOTCH3 variants cause familial partial lipodystrophy due to activation of senescence pathways Diabetes (IF 6.2) Pub Date : 2024-12-09 Abhimanyu Garg, Chao Xing, Anil K. Agarwal, Aundrea K. Westfall, Diana R. Tomchick, Xunzhi Zhang, Michelle Xing, Rebecca J. Brown
Despite elucidation of the molecular genetic basis of several lipodystrophy syndromes, molecular defects in some ultra-rare subtypes of familial lipodystrophies remain unidentified. We analyzed whole exome sequencing (WES) data of four affected and two unaffected females from an undiagnosed autosomal dominant familial partial lipodystrophy (FPL) pedigree and identified only one novel heterozygous variant
-
β-Cell Secretory Capacity Predicts Metabolic Outcomes over 6 Years following Human Islet Transplantation Diabetes (IF 6.2) Pub Date : 2024-12-04 Anneliese J. Flatt, Austin M. Matus, Robert J. Gallop, Eileen Markmann, Cornelia Dalton-Bakes, Amy J. Peleckis, Chengyang Liu, Ali Naji, Michael R. Rickels
Transplanted islet functional β-cell mass is measured by the β-cell secretory capacity derived from the acute insulin response to glucose-potentiated arginine (AIRpot), however, data are limited beyond one-year post-transplant for individuals with type 1 diabetes. We evaluated changes in β-cell secretory capacity in a single-center longitudinal analysis and examined relationships with measures of islet
-
Plasma proteomic signatures of adiposity are associated with cardiovascular risk factors and type 2 diabetes risk in a multi-ethnic Asian population. Diabetes (IF 6.2) Pub Date : 2024-12-02 Charlie G.Y. Lim, Bige Ozkan, Yujian Liang, Jingsha Chen, Jiali Yao, Nang Ei Ei Khaing, Mary R. Rooney, Chiadi E. Ndumele, E Shyong Tai, Josef Coresh, Xueling Sim, Rob M. van Dam
The biomarkers connecting obesity and cardiometabolic diseases are not fully understood. We aimed to (i) evaluate the associations between body mass index (BMI), waist circumference (WC), and ∼5,000 plasma proteins (SomaScan v4), (ii) identify protein signatures of BMI and WC, and (iii) evaluate the associations between the protein signatures and cardiometabolic health including metabolically unhealthy
-
Blocking adipocyte YY1 decouples thermogenesis from beneficial metabolism by promoting spermidine production Diabetes (IF 6.2) Pub Date : 2024-12-02 Chen Qiu, Yu Lu, Suyang Wu, Wenli Guo, Jiahao Ni, Jiyuan Song, Zichao Liu, Xiaoai Chang, Kai Wang, Peng Sun, Qian Zhang, Shufang Yang, Kai Li
The accumulation of mitochondria in thermogenic adipose tissue (i.e., brown and beige fat) increases energy expenditure, which can aid in alleviating obesity and metabolic disorders. However, recent studies have shown that knocking out key proteins required to maintain mitochondrial function inhibits the energy expenditure in thermogenic fat, and yet the knockout mice are unexpectedly protected from
-
Imaging human pancreatic endocrinogenesis during early prenatal life Diabetes (IF 6.2) Pub Date : 2024-11-27 Adrian Villalba, Yorick Gitton, Virginie Aiello, Maryne Toupin, Séverine Mazaud-Guittot, Alain Chédotal, Raphaël Scharfmann
Murine pancreatic endocrinogenesis has been extensively studied, but human data remain scarce due to limited sample availability. Here, we first built a large collection of human embryonic and fetal pancreases covering the first trimester of pregnancy to explore human endocrinogenesis. Using an experimental pipeline combining in toto staining, tissue clearing, and light-sheet fluorescence microscopy
-
Improved Afternoon Hepatic Glucose Disposal and Storage Requires Morning Engagement of Hepatic Insulin Receptors Diabetes (IF 6.2) Pub Date : 2024-11-27 Hannah L. Waterman, Mary Courtney Moore, Marta S. Smith, Ben Farmer, Kalisha Yankey, Melanie Scott, Dale S. Edgerton, Alan D. Cherrington
Glucose tolerance improves significantly upon consuming a second, identical meal later in the day (second meal phenomenon). We previously established that morning hyperinsulinemia primes the liver for increased afternoon hepatic glucose uptake (HGU). Although the route of insulin delivery is an important determinant of the mechanisms by which insulin regulates liver glucose metabolism (direct hepatic
-
Ablation of FAM210A in brown adipocytes of mice exacerbates high fat diet induced metabolic dysfunction Diabetes (IF 6.2) Pub Date : 2024-11-27 Jiamin Qiu, Mennatallah A. Khedr, Meijin Pan, Christina R. Ferreira, Jingjuan Chen, Madigan M. Snyder, Kolapo M. Ajuwon, Feng Yue, Shihuan Kuang
Thermogenesis of brown adipose tissues (BAT) provides metabolic benefits against pathological conditions such as Type 2 diabetes, obesity, cardiovascular diseases, and cancer. The thermogenic function of BAT relies on mitochondria, but whether mitochondrial remodeling is required for the beneficial effects of BAT remains unclear. We have recently identified FAM210A as a BAT-enriched mitochondrial protein
-
Resolving spatiotemporal electrical signaling within the islet via CMOS microelectrode arrays Diabetes (IF 6.2) Pub Date : 2024-11-25 Anne Gresch, Jana Osthues, Jan D. Hüwel, Jennifer K. Briggs, Tim Berger, Ruben Koch, Thomas Deickert, Christian Beecks, Richard K.P. Benninger, Martina Düfer
Glucose-stimulated beta-cells exhibit synchronized calcium dynamics across the islet that recruit beta-cells to enhance insulin secretion. Compared to calcium dynamics, the formation and cell-to-cell propagation of electrical signals within the islet are poorly characterized. To determine factors that influence the propagation of electrical activity across the islet underlying calcium oscillations
-
The IsletTester mouse: an immunodeficient model with stable hyperglycemia for the study of human islets Diabetes (IF 6.2) Pub Date : 2024-11-21 Eric L. Waite, Mark Tigue, Ming Yu, Deeksha Lahori, Kai Kelly, Catherine Lee May, Ali Naji, Jeffrey Roman, Nicolai Doliba, Dana Avrahami, Kim-Vy Nguyen-Ngoc, Maike Sander, Benjamin Glaser, Klaus H. Kaestner
The gold standard for assessing the function of human islets or β-like cells derived from stem cells involves their engraftment under the kidney capsule of hyperglycemic, immunodeficient mice. Current models, such as Streptozotocin (STZ) treatment of severely immunodeficient mice or the NRG-Akita strain are limited due to unstable and variable hyperglycemia and/or high morbidity of these models. To
-
Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes Diabetes (IF 6.2) Pub Date : 2024-11-21 Sky T. H. Ng, Michael J. Price, Naomi Richardson, Maher Nawaf, Alastair Copland, Heather B. Streeter, Parth Narendran, David C. Wraith
Dysregulation and loss of immune tolerance towards pancreatic β-cell autoantigens are features of type 1 diabetes (T1D). Until recently, life-long insulin injection was the only approved treatment for T1D, and this does not address the underlying disease pathology. Antigen-specific immunotherapy (ASI) seeks to restore tolerance and holds potential as a new therapeutic strategy for treating autoimmune
-
Tracking insulin- and glucagon-expressing cells in vitro and in vivo using a double reporter human embryonic stem cell line Diabetes (IF 6.2) Pub Date : 2024-11-19 Samantha Mar, Ekaterina Filatov, Shugo Sasaki, Majid Mojibian, Dahai Zhang, Angela Yang, Cuilan Nian, Francis C. Lynn
Human embryonic stem cell (hESC)-derived pancreatic alpha and beta cells can be used to develop cell replacement therapies to treat diabetes. However, recent published differentiation protocols yield varying amounts of alpha and beta cells amidst heterogeneous cell populations. To visualize and isolate hESC-derived alpha and beta cells, we generated a GLUCAGON-2AmScarlet and INSULIN-2A-EGFP dual fluorescent
-
Proteomic Signature of Body Mass Index and Risk of Type 2 Diabetes Diabetes (IF 6.2) Pub Date : 2024-11-19 Xuan Wang, Hao Ma, Minghao Kou, Yoriko Heianza, Vivian Fonseca, Lu Qi
The obesity diagnosis by body mass index (BMI) exhibits considerable interindividual heterogeneity in metabolic phenotypes and risk of developing type 2 diabetes (T2D). We investigated the association of proteomic signature of BMI and T2D and examined whether the proteomic signature of BMI improves prediction of T2D risk. This study included 41,427 adults in the UK Biobank who were free of T2D at baseline
-
Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes Diabetes (IF 6.2) Pub Date : 2024-11-19 Sevilay Tokgöz, Marti Boss, Theodorus JP Jansen, Rick Meijer, Cathelijne Frielink, Arianne C van Bon, Cees J Tack, Bastiaan E de Galan, Martin Gotthardt
Glucagon-like peptide 1 receptor (GLP-1R) agonists fail to reduce weight and improve glucose control in a sizable minority of people with type 2 diabetes. We hypothesized that stimulation of the hypothalamic-pituitary-adrenal (HPA) axis by GLP-1R agonists, thus inducing cortisol secretion, could explain this unresponsiveness to GLP-1R agonists. To assess the effects of GLP-1R agonist treatment on the
-
Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes Diabetes (IF 6.2) Pub Date : 2024-11-18 Delnaz Roshandel, Athina Spiliopoulou, Stuart J. McGurnaghan, Andrii Iakovliev, Debby Lipschutz, Caroline Hayward, Shelley B. Bull, Barbara E.K. Klein, Kris E. Lee, Gregory L. Kinney, Marian Rewers, Tina Costacou, Rachel G. Miller, Paul M. McKeigue, Andrew D. Paterson, Helen M. Colhoun
Identified genetic loci for C-peptide and age at diagnosis (AAD) in individuals with type 1 diabetes (T1D) explain only a small proportion of their variation. Here, we aimed to perform large metagenome-wide association studies (GWAS) of C-peptide and AAD in T1D; and to identify the HLA allele/haplotypes associated with C-peptide and AAD. 7,252 and 7,923 European individuals with T1D were included in
-
Stopping the intergenerational risk of diabetes – from mechanisms to interventions Diabetes (IF 6.2) Pub Date : 2024-11-18 Soren Harnois-Leblanc, Marie-France Hivert
Embedded in the Developmental Origins of Health and Disease hypothesis, maternal hyperglycemia in utero, from pre-existing diabetes or gestational diabetes mellitus, predisposes the offspring to excess adiposity and heightened risk of prediabetes and type 2 diabetes development. This transmission creates a vicious cycle increasing the presence of diabetes from one generation to another, leading to
-
Diabetes Mellitus Associated with Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype Diabetes (IF 6.2) Pub Date : 2024-11-18 Jean-Pierre Chanoine, David M Thompson, Anna Lehman
Maternally inherited diabetes and deafness (MIDD) is a monogenic mitochondrial disorder caused by a pathogenic variant in the MT-TL1 gene encoding for a leucine transfer RNA. We propose a new hypothesis that explains how the MT-TL1 variant causes impaired glucose tolerance and diabetes in MIDD. We suggest that diabetes in MIDD primarily depends on a variable combination of insulin resistance and impaired
-
Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6 Diabetes (IF 6.2) Pub Date : 2024-11-18 Dudley H. McNitt, Jonathan M. Williams, Joseph G. Santitoro, Jacob Kim, James W. Thomas, Rachel H. Bonami
High-affinity islet autoantibodies predict type 1 diabetes in mice and humans and implicate germinal centers (GCs) in type 1 diabetes pathogenesis. T follicular helper (Tfh) cells are increased in type 1 diabetic individuals and alterations in Tfh-like cells in the peripheral blood predicted individual responses to abatacept. Tfh cells support GC responses and depend on the transcriptional repressor
-
Identification of Metabolic Patterns in Korean Patients with Type 2 Diabetes Mellitus and their Association with Diabetes-Related Complications Diabetes (IF 6.2) Pub Date : 2024-11-15 Minji Kang, Kumhee Son, You-Cheol Hwang, Sihoon Lee, Hyunji Sang, Sunyoung Kim, Dong Keon Yon, Sang Youl Rhee, Hyunjung Lim
Resolving metabolic heterogeneity in patients with type 2 diabetes mellitus (T2DM) gives them access to precision medicine. Despite ethnic diversity in pathophysiological processes in individuals with T2DM, studies on subtypes of diabetes related to clinical characteristics in Asians are insufficient. This study aims to identify metabolic patterns in middle-aged patients with T2DM in Republic of Korea
-
Increased COX6A2 promotes pancreatic β-cell apoptosis and is suppressed in diabetic GK rats after Roux-en-Y gastric bypass Diabetes (IF 6.2) Pub Date : 2024-11-15 Xiangchen Kong, Dan Yan, Lianqi Shao, Bingfeng Li, Simian Lv, Yifan Tu, Yingqi Zhang, Xingsheng Shu, Ying Ying, Xiaosong Ma
Roux-en-Y gastric bypass (RYGB) has been shown to inhibit β-cell apoptosis, but the underlying mechanisms are not yet fully understood. Cytochrome c oxidase subunit 6A2 (COX6A2) is expressed in β-cells. Here, we sought to investigate the role of COX6A2 in β-cell apoptosis, especially following RYGB. We found that RYGB significantly reduced β-cell apoptosis, accompanied by decreased COX6A2 expression
-
Friend or foe: the paradoxical roles of MG53 in diabetes mellitus Diabetes (IF 6.2) Pub Date : 2024-11-13 Shuangshuang Yuan, Qin Yu, Mao Luo, Jianbo Wu, Liqun Wang
MG53 is predominantly expressed in striated muscles. The role of MG53 in diabetes mellitus has been gradually elucidated but is still full of controversy. Some reports have indicated that MG53 is upregulated in animal models with metabolic disorders, and that muscle-specific MG53 upregulation is sufficient to induce whole-body insulin resistance and metabolic syndrome through targeting both the insulin
-
Innovating Diabetes Care in Pregnancy: Do group care models improve outcomes and equity? Diabetes (IF 6.2) Pub Date : 2024-11-12 Ebony B. Carter
Shared medical appointments (SMAs) for diabetes and group prenatal care (GPC) for pregnant patients, have emerged as innovative care delivery models. They have the potential to transform diabetes care by overcoming many of the time limitations of traditional one-on-one clinical visits. There is compelling evidence that SMAs improve glycemic control for non-pregnant patients with diabetes, GPC reduces
-
The effect of small increases in blood glucose on insulin secretion and endogenous glucose production in humans Diabetes (IF 6.2) Pub Date : 2024-11-07 Clinton R. Bruce, Teddy Ang, Jason D. Toms, Giang M. Dao, Jean Liu, Glenn M. Ward, David N. O’Neal, Dale J. Morrison, Greg M. Kowalski
Small glycemic increments (≤0.5 mmol/L) can exert suppressive actions on endogenous glucose production (EGP) however it is unclear if this is an insulin dependent or independent process. Here, we performed a low-rate glucose infusion in control participants without diabetes and in people with type 1 diabetes (T1D) to better understand this phenomenon. Glucose kinetics, hormones and metabolites were
-
Nicotinic signaling stimulates glucagon secretion in mouse and human pancreatic α-cells Diabetes (IF 6.2) Pub Date : 2024-10-30 Alexander Hamilton, Quan Zhang, Rui Gao, Thomas Hill, Albert Salehi, Jakob G. Knudsen, Matthew Draper, Paul R.V. Johnson, Patrik Rorsman, Andrei I. Tarasov
Smoking is widely regarded as a risk factor for type 2 diabetes, as nicotine contributes to insulin resistance by desensitizing the insulin receptors in muscle, liver, or fat. Little is known, however, about the immediate regulation of islet hormonal output by nicotine, an agonist of ionotropic cholinergic receptors. We investigated this by imaging cytosolic Ca2+ dynamics in mouse and human islets
-
N 6-Methyladenosine demethylase FTO controls macrophage homeostasis in diabetic vasculopathy Diabetes (IF 6.2) Pub Date : 2024-10-24 Siguo Feng, Qiuyang Zhang, Qing Liu, Chang Huang, Huiying Zhang, Fengsheng Wang, Yue Zhu, Qizhi Jian, Xue Chen, Qin Jiang, Biao Yan
Diabetic vasculopathy, encompassing complications such as diabetic retinopathy, represents a significant source of morbidity, with inflammation playing a pivotal role in the progression of these complications. This study investigates the influence of m6A modification and the m6A demethylase FTO on macrophage polarization and its subsequent effects on diabetic microvasculopathy. We found that diabetes
-
Induction of a Müller glial-specific protective pathway safeguards the retina from diabetes induced damage Diabetes (IF 6.2) Pub Date : 2024-10-24 Cheng-Hui Lin, Man-Ru Wu, Bogdan Tanasa, Praveen Prakhar, Boxiong Deng, Alexander E. Davis, Liang Li, Alexander Xia, Yang Shan, Patrice E. Fort, Sui Wang
Diabetes can lead to cell-type-specific responses in the retina, including vascular lesions, glial dysfunction and neurodegeneration, all of which contribute to retinopathy. However, the molecular mechanisms underlying these cell type-specific responses, and the cell types that are sensitive to diabetes have not been fully elucidated. Employing single cell transcriptomics, we profiled the transcriptional
-
Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future Diabetes (IF 6.2) Pub Date : 2024-10-24 Roberto Mallone, Emily Sims, Peter Achenbach, Chantal Mathieu, Alberto Pugliese, Mark Atkinson, Sanjoy Dutta, Carmella Evans-Molina, David Klatzmann, Anne Koralova, S. Alice Long, Lut Overbergh, Teresa Rodriguez-Calvo, Anette-Gabriele Ziegler, Sylvaine You
Type 1 diabetes treatment stands at a crucial and exciting crossroad since the 2022 U.S. Food and Drug Administration (FDA) approval of teplizumab to delay disease development. In this Perspective article, we discuss four major conceptual and practical issues that emerged as key to further advance type 1 diabetes research and therapies. First, collaborative networks leveraging the synergy between the
-
Long-term nerve regeneration in diabetic keratopathy mediated by a novel NGF delivery system Diabetes (IF 6.2) Pub Date : 2024-10-24 Lin Cong, Benxiang Qi, Shijiu Chen, Ruiling Liu, Suxia Li, Qingjun Zhou, Yihai Cao, Bi Ning Zhang, Lixin Xie
Diabetic keratopathy (DK) is a common chronic metabolic disorder that causes ocular surface complications. Among various therapeutic approaches, local delivery of nerve growth factor (NGF) remains the most effective treatment for DK. However, achieving a sustained therapeutic effect with NGF and the frequent drug delivery burden remain challenging during clinical practice. Here, we developed a novel
-
Effect of Hyperketonemia on Myocardial Function in Patients with Heart Failure and Type 2 Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-24 Carolina Solis-Herrera, Yuejuan Qin, Henri Honka, Eugenio Cersosimo, Curtis Triplitt, Sivaram Neppala, Jemena Rajan, Francisca M. Acosta, Alexander J. Moody, Patricio Iozzo, Peter Fox, Geoffrey Clarke, Ralph A. DeFronzo
We examined the effect of increased plasma ketones on left ventricular (LV) function, myocardial glucose uptake (MGU), and myocardial blood flow (MBF) in type 2 diabetes (T2DM) patients with heart failure (HF). Three groups (I,II,III) of T2DM (12 per group) with LV ejection fraction ≤50% received incremental infusions of β-OH-B for 3-6 hours to raise plasma β-OH-B concentration throughout the physiologic
-
IER3IP1 mutations cause neonatal diabetes due to impaired proinsulin trafficking Diabetes (IF 6.2) Pub Date : 2024-10-23 Hossam Montaser, Sonja Leppänen, Eliisa Vähäkangas, Nils Bäck, Alicia Grace, Solja Eurola, Hazem Ibrahim, Väinö Lithovius, Samuel B. Stephens, Tom Barsby, Diego Balboa, Jonna Saarimäki-Vire, Timo Otonkoski
Immediate early response 3 interacting-protein 1 (IER3IP1) is an endoplasmic reticulum resident protein, highly expressed in pancreatic cells and the developing brain cortex. Homozygous mutations in IER3IP1 have been found in individuals with microcephaly and neonatal diabetes, yet the underlying mechanism causing beta cell failure remains unclear. Here, we utilized differentiation of genome edited-stem
-
Neurodevelopmental Pathways to Obesity and Type 2 Diabetes: Insights From Prenatal Exposure to Maternal Obesity and Gestational Diabetes Mellitus: A Report on Research Supported by Pathway to Stop Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-21 Kathleen A. Page
Incidences of childhood obesity and type 2 diabetes (T2D) are climbing at alarming rates. Evidence points to prenatal exposures to maternal obesity and gestational diabetes mellitus (GDM) as key contributors to these upward trends. Children born to mothers with these conditions face higher risks of obesity and T2D, beyond genetic or shared environmental factors. The underpinnings of this maternal-fetal
-
Multi-Omics Mendelian Randomization Study Investigating the Impact of PCSK9 and HMGCR Inhibition on Type 2 Diabetes Across Five Populations Diabetes (IF 6.2) Pub Date : 2024-10-17 Daniel B. Rosoff, Josephin Wagner, Jeesun Jung, Pal Pacher, Constantinos Christodoulides, George Davey Smith, David Ray, Falk W. Lohoff
The prevalence of type 2 diabetes (T2D) varies among populations of different race/ethnicity. The influence of genetically-proxied lipoprotein cholesterol (LDL-C) lowering through proprotein convertase subtilisin/kexin 9 (PCSK9) and HMG-CoA Reductase (HMGCR) on T2D in non-European populations is not well established.A drug-target Mendelian randomization (MR) approach was used to assess the effects
-
When does metabolic memory start? Insights from the AMD Annals Initiative on stringent HbA1c targets. Diabetes (IF 6.2) Pub Date : 2024-10-17 Giuseppina T. Russo, Antonio Nicolucci, Giuseppe Lucisano, Maria Chiara Rossi, Antonio Ceriello, Francesco Prattichizzo, Valeria Manicardi, Alberto Rocca, Paolo Di Bartolo, Salvatore De Cosmo, Graziano Di Cianni, Riccardo Candido
Early, intensive glycemic control in T2D patients is associated with long-term benefits on cardiovascular disease (CVD) development. Evidence on benefits of achieving HbA1c targets close to normal values is scant. Subjects with newly-diagnosed T2D, without CVD at baseline, were identified in an Italian clinical registry (N=251,339). We adopted three definitions of early exposure periods (0–1, 0–2 and
-
Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and Targets Diabetes (IF 6.2) Pub Date : 2024-10-17 Daniel Schwarz, Maxime Le Marois, Volker Sturm, Andreas S. Peters, Rémi Longuespée, Dominic Helm, Martin Schneider, Bastian Eichmüller, Asa S. Hidmark, Manuel Fischer, Zoltan Kender, Constantin Schwab, Ingrid Hausser, Joachim Weis, Susanna Dihlmann, Dittmar Böckler, Martin Bendszus, Sabine Heiland, Stephan Herzig, Peter P. Nawroth, Julia Szendroedi, Thomas Fleming
Lesioned fascicles (LF) in the sciatic nerves of individuals with diabetic neuropathy (DN) correlate with clinical symptom severity. This study aimed to characterize the structural and molecular composition of these lesions to better understand DN pathogenesis. Sciatic nerves from amputees with and without type 2 diabetes (T2D) were examined using ex vivo magnetic resonance neurography, in vitro imaging
-
1-hour postload glucose is a more sensitive marker of impaired β-cell function than 2-hour postload glucose Diabetes (IF 6.2) Pub Date : 2024-10-17 Jingyi Lu, Jiaying Ni, Hang Su, Xingxing He, Wei Lu, Wei Zhu, Yufei Wang, Xiaojing Ma, Yuqian Bao, Jian Zhou
There is evidence that 1-h plasma glucose (PG) during the 75-g oral glucose tolerance test (OGTT) is superior to 2-h PG in predicting diabetes. We aimed to investigate the characteristics of insulin sensitivity and β-cell function behind this observation. After age, sex and BMI matching, 496 subjects selected from 3965 non-diabetic individuals at high risk of type 2 diabetes in a tertiary medical center
-
Functionally Separate Populations of Ventromedial Hypothalamic Neurons in Obesity and Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-17 Jonathan N. Flak
The Ventromedial hypothalamic nucleus (VMN) maintains healthy metabolic function through several important roles. Collectively, homeostasis is maintained via intermingled cells within the VMN that raise blood glucose, lower blood glucose, and stimulate energy expenditure when needed. This perspective discusses the defining factors for the VMN cell types that govern distinct functions induced by the
-
Evaluating the causal effect of circulating proteome on the glycemic traits: Evidence from Mendelian randomization Diabetes (IF 6.2) Pub Date : 2024-10-17 Xing Xing, Siqi Xu, Yining Wang, Ziyuan Shen, Simin Wen, Yan Zhang, Guangfeng Ruan, Guoqi Cai
Exploring the mechanisms underlying abnormal glycemic traits is important for deciphering type 2 diabetes and characterizing novel drug targets. This study aimed to decipher the causal associations of circulating proteins with fasting glucose (FG), 2-h glucose after an oral glucose challenge (2hGlu), fasting insulin (FI), and glycated hemoglobin (HbA1c) using large-scale proteome-wide Mendelian randomization
-
Brain Defense of Glycemia in Health and Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-14 Zaman Mirzadeh, Chelsea Faber
The brain coordinates the homeostatic defense of multiple metabolic variables, including blood glucose levels, in the context of ever-changing external and internal environments. The biologically defended level of glycemia (BDLG) is the net result of brain modulation of insulin-dependent mechanisms in cooperation with the islet, and insulin-independent mechanisms through direct innervation and neuroendocrine
-
NMDA Receptors in POMC Neurons Connect Exercise With Insulin Sensitivity Diabetes (IF 6.2) Pub Date : 2024-10-14 Bryan Portillo, Eunsang Hwang, Jason Ajwani, Kyle Grose, Linh Lieu, Briana Wallace, Anita Kabahizi, Joel K. Elmquist, Kevin W. Williams
Increased arcuate proopiomelanocortin (POMC) neuron activity improves glucose metabolism and reduces appetite, facilitating weight loss. We recently showed that arcuate POMC neurons are activated by exercise. However, the role of excitatory glutamatergic input in these neurons and the metabolic outcomes of exercise remains undefined. To investigate this, we developed a mouse model with NMDA receptors
-
One Nervous System: Critical Links Between Central and Peripheral Nervous System Health and Implications for Obesity and Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-14 Kristy L. Townsend
There are key differences between the central nervous system (CNS) (brain and spinal cord) and peripheral nervous system (PNS), such as glial cell types, whether there is protection by the blood-brain barrier, modes of synaptic connections, etc. However, there are many more similarities between these two arms of the nervous system, including neuronal structure and function, neuroimmune and neurovascular
-
Role of Sec61α2 translocon in insulin biosynthesis Diabetes (IF 6.2) Pub Date : 2024-09-26 Xiaoxi Xu, Thomas W. Bell, Truc Le, Ivy Zhao, Emily Walker, Yiqing Wang, Ning Xu, Scott A. Soleimanpour, Holger A. Russ, Ling Qi, Billy Tsai, Ming Liu, Peter Arvan
Translocational regulation of proinsulin biosynthesis in pancreatic β-cells is unknown, although several studies have reported an important accessory role for the Translocon-Associated Protein complex to assist preproinsulin delivery into the endoplasmic reticulum via the heterotrimeric Sec61 translocon (comprised of α, β, and γ subunits). The actual protein-conducting channel is the α–subunit encoded
-
Deficiency of the hemoglobin-haptoglobin receptor, CD163, worsens insulin sensitivity in obese male mice Diabetes (IF 6.2) Pub Date : 2024-09-26 Michael W. Schleh, Magdalene Ameka, Alec Rodriguez, Hasty Alyssa H.
Excessive iron accumulation in metabolic organs such as the adipose tissue, liver, and skeletal muscle is associated with increased diabetes risk. Tissue-resident macrophages serve multiple roles including managing inflammatory tone and regulating parachymal iron homeostasis; thus protecting against metabolic dysfunction upon iron overload. The scavenger receptor CD163 is uniquely present on tissue-resident
-
Optimised proteomic analysis of insulin granules from MIN6 cells identifies Scamp3, a novel regulator of insulin secretion and content. Diabetes (IF 6.2) Pub Date : 2024-09-25 Nicholas Norris, Belinda Yau, Carlo Famularo, Hayley Webster, Thomas Loudovaris, Helen E. Thomas, Mark Larance, Alistair M. Senior, Melkam A. Kebede
Pancreatic β-cells in the Islets of Langerhans are key to maintaining glucose homeostasis, by secreting the peptide hormone insulin. Insulin is packaged within vesicles named insulin secretory granules (ISGs), that have recently been considered to have intrinsic structures and proteins that regulate insulin granule maturation, trafficking, and secretion. Previously, studies have identified a handful
-
Microglia Mediate Metabolic Dysfunction from Common Air Pollutants through NF-κB Signaling Diabetes (IF 6.2) Pub Date : 2024-09-25 Lucas K. Debarba, Hashan S.M. Jayarathne, Lukas Stilgenbauer, Ana L.Terra dos Santos, Lisa Koshko, Sydney Scofield, Ryan Sullivan, Abhijit Mandal, Ulrike Klueh, Marianna Sadagurski
The prevalence of Type 2 Diabetes (T2D) poses a significant health challenge yet the contribution of air pollutants to T2D epidemics remains understudied. Several studies demonstrated a correlation between exposure to volatile organic compounds (VOCs) in indoor/outdoor environments, and T2D. Here, we conducted the first meta-analysis, establishing a robust association between exposure to benzene, a
-
Podocyte-Specific Expression of the Stress Response Protein REDD1 is Necessary for Diabetes-induced Podocytopenia Diabetes (IF 6.2) Pub Date : 2024-09-25 Siddharth Sunilkumar, Esma I. Yerlikaya, Allyson L. Toro, Han Chen, Yandong Zhou, Donald L. Gill, Scot R. Kimball, Michael D. Dennis
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease and effective treatment modalities that fully address its molecular etiology are lacking. Prior studies support that the stress response protein REDD1 (Regulated in Development and DNA Damage 1) contributes to the development of diabetic complications. This study investigated a potential role for REDD1 expression in podocytes
-
Extracellular cleavage of microglia-derived progranulin promotes diet-induced obesity Diabetes (IF 6.2) Pub Date : 2024-09-20 Chae Beom Park, Chan Hee Lee, Kae Won Cho, Sunghun Shin, Won Hee Jang, Junyeong Byeon, Yu Rim Oh, Sung Jun Kim, Jae Woo Park, Gil Myoung Kang, Se Hee Min, Seyun Kim, Rina Yu, Min-Seon Kim
Hypothalamic innate immune responses to dietary fats underpin the pathogenesis of obesity, in which microglia play a critical role. Progranulin (PGRN) is an evolutionarily -conserved secretory protein containing seven-and-a-half granulin (GRN) motifs. It is cleaved into GRNs by multiple proteases. In the central nervous system, PGRN is highly expressed in microglia. To investigate the role of microglia-derived
-
Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People with Obesity and Type 2 Diabetes Diabetes (IF 6.2) Pub Date : 2024-09-12 Max C. Petersen, Mihoko Yoshino, Gordon I. Smith, Rafael C. Gaspar, Mario Kahn, Dmitri Samovski, Gerald I. Shulman, Samuel Klein
Muscle sn-1,2-diacylglycerol (DAG) and C18:0 ceramide accumulation in sarcolemmal and mitochondrial compartments have been proposed to regulate muscle insulin sensitivity. Here, we evaluated whether weight loss-induced improvements in insulin sensitivity were associated with changes in muscle sn-1,2-DAG and ceramide content in people with obesity and type 2 diabetes. We measured skeletal muscle insulin
-
A Single Dose of Phosphoinositide-3-kinase Inhibitor Alpelisib Induces Insulin Resistance in Healthy Adults: A Randomized Feasibility Study Diabetes (IF 6.2) Pub Date : 2024-09-12 Joshua R. Cook, Nur Bedeir, Zachary D. Sone, Julia Wattacheril, Henry N. Ginsberg, Blandine Laferrère
Our objective is to test a single dose of the phosphoinositide-3-kinase (PI3K) inhibitor alpelisib as a tool for acute modeling of insulin resistance in healthy volunteers. This single-center, double-blind, phase 1 clinical trial randomized healthy adults to take a single oral dose of alpelisib 300 mg (n = 5) or placebo (n = 6) at bedtime, followed by measurement of glucose, insulin, and C-peptide
-
CRTC1 in Mc4r-expressing cells is required for peripheral metabolism and systemic energy homeostasis Diabetes (IF 6.2) Pub Date : 2024-09-12 Haruka Miyamori, Takumi Yokokawa, Motoki Miyakita, Kazuki Ozaki, Tsuyoshi Goto, Kazuo Inoue, Shigenobu Matsumura
Melanocortin-4-receptor (Mc4r) is a G protein-coupled receptor (GPCR) that controls systemic energy balance by regulating food intake and energy expenditure. Although the detailed molecular mechanism remains unclear, the activation of cAMP signaling in Mc4r-expressing cells reportedly suppresses food intake and increases energy expenditure. cAMP-responsive element-binding protein-regulated transcriptional
-
Erratum. 189-OR: Food Insecurity and Inability to Obtain Recommended Medications, Diabetes Technology, and Multidisciplinary Services in Youth and Young Adults with Diabetes. Diabetes 2024;73 (Suppl. 1):189-OR Diabetes (IF 6.2) Pub Date : 2024-08-29 Angela D. Liese, Emmanuel F. Julceus, Caroline Rudisill, Faisal Malik, Kate Flory, Edward A. Frongillo, Katherine A. Sauder, Jason A. Mendoza
In the abstract cited above, author Nadine El Kalach was inadvertently omitted from the author list. The full, correct author list is as follows: Nadine El Kalach, Emmanuel F. Julceus, Caroline Rudisill, Faisal Malik, Kate Flory, Edward A. Frongillo, Katherine A. Sauder, Jason A. Mendoza, and Angela D. Liese. All authors approve the addition and the order of the revised author list. The authors apologize
-
Glucagon Stimulation Test and Insulin Secretory Capacity in Clinical Assessment of Incretin-Based Therapy for Diabetes Diabetes (IF 6.2) Pub Date : 2024-08-28 Takuya Haraguchi, Yuji Yamazaki, Hitoshi Kuwata, Ryota Usui, Yoshiyuki Hamamoto, Yutaka Seino, Daisuke Yabe, Yuichiro Yamada
Evaluation of insulin secretory capacity is essential to understand the pathophysiological condition of individuals with diabetes and to assess the efficacy of drugs used in treatment of the disease. The 1 mg intravenous glucagon stimulation test (GST) is widely used to evaluate residual β cell function; we previously reported that GST assessment of insulin secretory capacity is useful in assessing
-
Visceral adipocyte-derived extracellular vesicle miR-27a-5p elicits glucose intolerance by inhibiting pancreatic β-cell insulin secretion Diabetes (IF 6.2) Pub Date : 2024-08-26 Yaqin Zhang, Bin Qian, Yang Yang, Fandi Niu, Changsong Lin, Honglei Yuan, Jianan Wang, Tijun Wu, Yixue Shao, Shulin Shao, Aiming Liu, Jingwen Wu, Peng Sun, Xiaoai Chang, Yan Bi, Wei Tang, Yunxia Zhu, Fang Chen, Dongming Su, Xiao Han
Pancreatic β-cell dysfunction caused by obesity can be associated with alterations in the levels of microRNAs (miRNAs). However, the role of miRNAs in such processes remains elusive. Here, we show that pancreatic islet miR-27a-5p, which is markedly increased in obese mice and impairs insulin secretion, is mainly delivered by visceral adipocyte-derived extracellular vesicles (EVs). Depleting miR-27a-5p
-
Müller cells harboring exosomal lncRNA OGRU modulates microglia polarization in diabetic retinopathy via serving as miRNA sponges Diabetes (IF 6.2) Pub Date : 2024-08-23 ShuHua Fu, WenJing Sun, Lu Liu, JiPing Xiao, Jian Xiong, YaoYun Hu, QianQian Zhou, XiaoLong Yin
Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus which is associated with visual loss and blindness worldwide. However, the effective treatments for both early- and late-stage DR remains lacking. A streptozotocin (STZ)-induced diabetic mice model and high glucose (HG)-treated Müller cell model were established. M1/M2 microglia polarization was assessed by immunofluorescence
-
Leptin activation of dorsal raphe neurons inhibits feeding behavior Diabetes (IF 6.2) Pub Date : 2024-08-22 Nicholas David Maxwell, Cora Elizabeth Smiley, Alia Tereza Sadek, Frances Zoe Loyo-Rosado, Daniel Christian Giles, Victoria Alice Macht, Jennifer Lynn Woodruff, Donzelle Lee Taylor, Victoria Marie Glass, Steven Peter Wilson, Lawrence Patrick Reagan, James Robert Fadel, Claudia Alejandra Grillo
Leptin is a homeostatic regulatory element that signals the presence of adipocyte energy stores, reduces food intake, and increases energy expenditure. Similarly, serotonin (5- HT), a signaling molecule found in both the central and peripheral nervous systems, also controls food intake. Using neuronal tract-tracing, pharmacological and optogenetics approaches, and in vivo microdialysis, combined with
-
Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop Diabetes (IF 6.2) Pub Date : 2024-08-22 Carla J. Greenbaum, Gerald T. Nepom, Lauren K. Wood-Heickman, Diane K. Wherrett, Linda A. DiMeglio, Kevan C. Herold, Jeffrey P. Krischer
The approval of teplizumab to delay the onset of type 1 diabetes is an important inflection point in the decades long pursuit to treat the cause of the disease rather than its symptoms. NIDDK convened a workshop of the Diabetes Mellitus Interagency Coordinating Committee titled “Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes” to review this accomplishment and identify
-
The effect of metformin on peripheral nerve morphology in type 2 diabetes: a cross-sectional observational study Diabetes (IF 6.2) Pub Date : 2024-08-21 Roshan Dhanapalaratnama, Tushar Issar, Leiao Leon Wang, Darren Tran, Ann M. Poynten, Kerry-Lee Milner, Natalie CG. Kwai, Arun V. Krishnan
Diabetic peripheral neuropathy (DPN) affects around 50% of the 500 million people with type 2 diabetes worldwide and is considered disabling and irreversible. The present study was undertaken to assess the effect of metformin on peripheral neuropathy outcomes in type 2 diabetes. 69 type 2 diabetes participants receiving metformin were recruited and underwent clinical assessment, peripheral nerve ultrasound
-
Pancreatic β cell TRAPδ deficiency reduces insulin production but improves insulin sensitivity Diabetes (IF 6.2) Pub Date : 2024-08-21 Jiyun Guo, Yanshu Yang, Ning Xu, Xin Li, Ying Yang, Wenli Feng, Yuanyuan Ye, Xiaoxi Xu, Jingqiu Cui, Ming Liu, Yumeng Huang
The translocon-associated protein-δ (TRAPδ) plays a role in insulin biosynthesis within pancreatic β cells. However, its pathophysiological significance in maintaining islet β cell function and glucose homeostasis remains unclear. In this study, we generated a mouse model featuring pancreatic β cell-specific deletion of TRAPδ (TRAPδ βKO). Our findings revealed that TRAPδ βKO resulted in decreased circulating
-
Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps formation on Type 1 Diabetes pathogenesis Diabetes (IF 6.2) Pub Date : 2024-08-13 Yiming Shen, Ruiya Shi, ShiPing Lu, Yan Wang, Ziqi Zhou, Chenhua Wu, Qi You, Hongye Fan, Jie Wu
Excessive macrophage extracellular traps (METs) formation has been implicated in several autoimmune disease pathogenesis; however, its impact on Type 1 Diabetes (T1D) and related mechanisms remains enigmatic. Here, we demonstrated the pivotal role of peptidyl arginine deiminase 4 (PAD4) in driving profuse METs formation and macrophage M1 polarization in intestinal inflammation of non-obese diabetic
-
PNLIPRP1 hypermethylation in exocrine pancreas links type 2 diabetes and cholesterol metabolism Diabetes (IF 6.2) Pub Date : 2024-08-13 Lucas Maurin, Lorella Marselli, Mathilde Boissel, Lijiao Ning, Raphael Boutry, Justine Fernandes, Mara Suleiman, Carmela De Luca, Audrey Leloire, Vincent Pascat, Bénédicte Toussaint, Souhila Amanzougarene, Mehdi Derhourhi, Anne Jörns, Sigurd Lenzen, François Pattou, Julie Kerr-Conte, Mickaël Canouil, Piero Marchetti, Amélie Bonnefond, Philippe Froguel, Amna Khamis
We postulated that T2D predisposes to exocrine pancreatic diseases through (epi)genetic mechanisms. We explored the methylome (methylationEPIC arrays) of the exocrine pancreas of 141 donors, assessing the impact of T2D. Epigenome-wide association study (EWAS) for T2D identified a hypermethylation in an enhancer of the Pancreatic-Lipase-Related-Protein 1 (PNLIPRP1) gene, associated with decreased PNLIPRP1